Advancing Precision Oncology with AI at ASCO 2026
BostonGene is presenting new findings at ASCO 2026 that demonstrate how AI-powered models and comprehensive molecular profiling can help identify biomarkers, predict treatment response, and support more informed clinical decision-making in cancer care.
Discover the latest innovations shaping the future of precision oncology: https://bostongene.com/news-an....d-publications/news/